| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Amyotrophic lateral sclerosis | 14 | 5 | |
| Aging | 4 | 0 | |
| General health | 2 | 0 | |
| Mitochondrial myopathy | 2 | 1 | |
| Chronic inflammatory demyelinating polyneuropathy | 1 | 3 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Nausea | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 10 |